Format

Send to

Choose Destination
JAMA Oncol. 2019 Aug 22. doi: 10.1001/jamaoncol.2019.3221. [Epub ahead of print]

Association Between Immune-Related Adverse Events During Anti-PD-1 Therapy and Tumor Mutational Burden.

Author information

1
Institute of Immunobiology, Kantonsspital St Gallen, St Gallen, Switzerland.
2
Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
3
Division of Translational Medicine, Department of Medicine, NYU School of Medicine, New York, New York.

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center